is yerba mate a glp-1 agonist The Incretin Effect of Maté (Ilex paraguariensis) Partially Dependent on Gut-Mediated Metabolism of Ferulic Acid Effect of yerba mate (Ilex

In early phase 2a trials, it effectively improved glycemic control, increased post-meal insulin levels, and facilitated weight loss in participants with obesity and patients with T2DM [83]

With the availability of multiple drug therapies demonstrating promising efficacy, we expect market competition to produce downward pressure on prices, most likely in the form of rebates for GLP-1s

The regulatory environment: The compounded GLP-1 medication space has been under increased regulatory scrutiny

[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Mojsov S

For pharmacies, these differences translate into distinct dispensing patterns